Handelsbanken Fonder’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Handelsbanken Fonder’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-266,260	Closed	-$14M	–	1572
2020 Q3	$14M	Sell	266,260 -130,000	-33%	-$5.38M	0.1%	199
2020 Q2	$13.2M	Buy	+396,260	New	+$12.6M	0.11%	185

Handelsbanken Fonder's MNTA Position: Q4 2020 in Review

Handelsbanken Fonder sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 266,260 shares — an estimated $14M sold.

Handelsbanken Fonder first reported a position in MNTA in Q2 2020 and held it in 2 quarters. The position peaked at $14M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Handelsbanken Fonder reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Handelsbanken Fonder sold 266,260 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $14M.
Handelsbanken Fonder first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 2 quarters.
Handelsbanken Fonder's Momenta Pharmaceuticals, Inc. position peaked at $14M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.